You are here

Vygart

Argenx' Vyvgart launch in CIDP picks up as the company barrels toward 10 indications by 2030

Fierce Pharma

Sun, 11/3/24 - 10:13 pm

Argenx's Vyvgart gains commercial momentum in gMG as company plots expansion into new uses

Fierce Pharma

Wed, 11/1/23 - 11:04 am

myasthenia gravis

Argenx's Vygart launch finds quick neurologist support over AstraZeneca's well-entrenched Soliris for myasthenia gravis

Fierce Pharma

Thu, 02/17/22 - 11:13 pm

myasthenia gravis